potassium superoxide has been researched along with bosentan anhydrous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves-Filho, JC; Casagrande, R; Cunha, FQ; Cunha, TM; Fattori, V; Navarro, SA; Pinho-Ribeiro, FA; Serafim, KG; Verri, WA; Zarpelon, AC | 1 |
1 other study(ies) available for potassium superoxide and bosentan anhydrous
Article | Year |
---|---|
Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Bosentan; Cytokines; Endothelin Receptor Antagonists; Hyperalgesia; Leukocytes; Male; Mice; Pain; Peritoneal Cavity; Peroxidase; Skin; Spinal Cord; Sulfonamides; Superoxides | 2015 |